Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Linezolid
Linezolid 600mg
Film coated tablet
Neo Health (NZ) Limited
Pharmaceutical Works Polpharma SA, Gdanski, Poland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Linezolid
Linezolid 600mg/300mL
Solution for infusion
Neo Health (NZ) Limited
Pharmaceutical Works Polpharma SA, Gdanski, Poland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Linezolid Juno
Linezolid 600mg
Film coated tablet
Neo Health (NZ) Limited
Pharmaceutical Works Polpharma SA, Gdanski, Poland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Linezolid Juno
Linezolid 600mg/300mL
Solution for infusion
Neo Health (NZ) Limited
Pharmaceutical Works Polpharma SA, Gdanski, Poland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Semglee
Insulin glargine 100IU/mL
Solution for injection
Mylan New Zealand Limited
Biocon Sdn Bhd, Nusajaya, Malaysia
|
Dated this 29th day of April 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz